Melior Discovery is a leading pharmaceutical development company based in Exton, PA, specializing in in vivo pharmacology platforms and disease models to unlock the untapped value of therapeutics.
With a DEA license for Schedule I-V substances, Melior Discovery offers a range of services, including theraTRACE and opioidTRACE, to provide efficacy models and resources for drug discovery and development.
Generated from the website